Ricarda Rauschenberg

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Correction: 1H-NMR serum metabolomic profiling from clinical routine identifies signatures of progressive melanoma metastasis.

Correction: 1H-NMR serum metabolomic profiling from clinical routine identifies signatures of progressive melanoma metastasis.

Journal: Scientific reports

Published: July 08, 2026

Real-world data on anti-PD-1 plus lenvatinib as a treatment option in pretreated advanced melanoma patients - a retrospective DeCOG study.

Real-world data on anti-PD-1 plus lenvatinib as a treatment option in pretreated advanced melanoma patients - a retrospective DeCOG study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 25, 2026

Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma.

Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 30, 2024

An open-label, single-arm, phase II trial of buparlisib in patients with melanoma brain metastases not eligible for surgery or radiosurgery-the BUMPER study.

An open-label, single-arm, phase II trial of buparlisib in patients with melanoma brain metastases not eligible for surgery or radiosurgery-the BUMPER study.

Journal: Neuro-oncology advances

Published: December 11, 2020

Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.

Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.

Journal: Nature medicine

Published: June 21, 2020

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.

Journal: Nature medicine

Published: March 25, 2019

Successful immunotherapy and irradiation in a HIV-positive patient with metastatic Merkel cell carcinoma.

Successful immunotherapy and irradiation in a HIV-positive patient with metastatic Merkel cell carcinoma.

Journal: Clinical and translational radiation oncology

Published: November 23, 2018

Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma.

Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 21, 2018

Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases.

Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 24, 2018

Unmet information needs of patients with melanoma in Germany.

Unmet information needs of patients with melanoma in Germany.

Journal: Melanoma research

Published: May 23, 2018

Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations-Chances and Challenges.

Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations-Chances and Challenges.

Journal: American journal of clinical dermatology

Published: February 09, 2018

Information-seeking and use of information resources among melanoma patients of German skin cancer centers.

Information-seeking and use of information resources among melanoma patients of German skin cancer centers.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: November 20, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026